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ABSTRACT
Antibodies are an essential component of the adaptive immune system that function to neutralize foreign invaders,
such as bacterial and parasitic pathogens. However, B-cell epitopes remain difficult to predict due to their general
indistinguishability from other protein regions. Epitope prediction tools in the past have largely relied on amino acid
sequence similarity; however, implementing three-dimensional protein structure analyses into the epitope prediction
algorithms has been shown to increase detection accuracy. Furthermore, structural comparisons between antigenic
proteins for their potential to bind cross-reactive antibodies have not been explored extensively in the literature.
Recent studies have pointed to the utility of looking at shared epitope structures in predicting antibody cross-
reactivity, which may shed light on cross-immunity between infectious pathogens and autoimmune diseases induced
after infection. Thus, herein, the potential impact of including structural similarity comparisons in detecting shared
epitopes is discussed. With the large amount of structural information being determined by three-dimensional
computational protein modelling methods, the ability to perform these analyses is becoming more feasible.
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DESCRIPTION
Antibodies are an essential component of the adaptive innate
immune system [1]. In response to activation by upstream
immune events, B-cells produce and secrete antibodies that can
bind to antigens, such as cell surface proteins from infectious
pathogens, in order to inhibit antigen activity directly or to
target the antigen for recognition by phagocytic cells or the
complement system [2]. The identification and prediction of
antibody-binding motifs, or epitopes, is important for
understanding immunogenicity of both pathogenic and
endogenous biomolecules and, as a result, developing
therapeutic antibodies or vaccines [3,4].
Antibody-antigen interfaces are treated as a specific type of
protein-protein interaction and, thus, epitopes have been
classified into two categories: contiguous amino acids in
sequence that comprise a linear motif or discontinuous stretches
of residues that fold together in three-dimensional space to
create a structural motif [5]. Sun et al. reviewed antibody-antigen
interfaces and found that linear and conformational motifs
make-up 10% and 90% of B-cell epitopes, respectively [6].
Despite the interest in epitope identification, the computational
prediction of B-cell epitopes has been proven somewhat difficult,
since epitope and non-epitope regions on protein surfaces are
generally indistinguishable from one another [7]. B-cell epitope
prediction methods in the past have largely focused on sequence
similarity; however, in order to more accurately predict
conformational epitopes that comprise discontinuous regions of
sequence, recent bioinformatics tools and pipelines have
implemented structural information to optimize epitope
detection [8]. Conformational epitope prediction tools and
databases, such as Disco tope and CED, respectively, include
parameters that account for protein domain solvent accessibility
and flexibility, which have been shown to increase prediction
accuracy [9,10]. Thus, more in-depth structural analysis may lend
insights into B-cell epitope detection and characterization.
Although structural information has been shown as useful in
predicting B-cell conformational epitopes, discussion of the
comparisons of structures to elucidate epitopes shared between
proteins is limited in the literature. Structural similarity has been
demonstrated as an accurate predictor for protein-protein
interactions; thus, it raises the question as to whether it can
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provide informative structural insights for epitope comparisons
[11]. The antigenic similarity prediction algorithm and database,
CE-BLAST, was developed based on defined antibody-antigen
complexes in PDB [12,13]. Although successful in finding shared
features between dengue virus and zika virus antigen structures,
the database is limited by the relatively small number of
structurally-defined epitopes and is missing information on post-
translational modifications (e.g. glycosylation, palmitoylation).
Comparing a broader diversity of antigenic structures may better
inform shared conformational epitope prediction between
proteins.
Recently, a comprehensive protein structure alignment screen
was performed using the antigenic and accessible receptor-
binding motifs of the spike proteins from highly pathogenic
coronaviruses and found several structurally similar human
proteins and antigenic proteins from viral, bacterial, and
parasitic pathogens [14]. Interestingly, the receptor-binding motif
from one of the studied coronaviruses, the Severe Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), was found to be
structurally similar to antigenic proteins from pathogens, such as
Plasmodium falciparum, that have been found to be inversely
correlated with SARS-CoV-2 infection [15,16]. Domains from
human proteins, such as those found in coagulation cascades,
were also found to be similar in structure, and this may partially
explain autoimmune diseases arising in infected or vaccinated
patients [17]. Further inspection of the structural alignments
reveals that sequence identity can be low considering normal
epitope-prediction methods, even though the prevalence of
electrostatically similar amino acids was quite high. Although
these observations require experimental validation, the
widespread similarity of these epitopes to other proteins draws
attention to the utility of high resolution structural similarity
investigations of antigenic protein surface regions. Thus, the use
of antigenic structural similarity may be a way to quickly and
comprehensively scan for structural motifs that support
recognition by similar antibodies.
The assessment of structural similarity in epitope prediction
algorithms, after refinement using parameters like solvent
accessibility, may help delineate cross-immunity between
different pathogens as well as human proteins and proteins from
pathogens giving rise to autoimmune-induced diseases. One of
the primary setbacks thus far in using structure-based methods
to predict epitopes has been the lack of available structural
templates in the PDB, due to the time it takes to generate an
experimentally-defined structure. However, as large-scale human
and pathogen protein databases are becoming more frequently
created using homology and ab initio computational three-
dimensional modelling approaches, as exemplified in the
proteome-wide modeled databases of Mycobacterium and
Plasmodium species, more structural features are becoming
known that can be used for structural comparisons [18-24].
CONCLUSION
The inclusion of additional annotations, such as
transmembrane domains, post-translational modifications, and
protomer surfaces involved in oligomerization, will be helpful to
create biologically-relevant models that can be used for more
accurate structural comparisons. The use of structural similarity
to predict antibody-antigen interactions may further the
understanding of antibody specificity and cross-reactivity.
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